Association of anemia with long-term renal prognosis in autosomal dominant polycystic kidney disease using time-series analysis.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Scientific Reports

• Publication date

  2026-02-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41598-026-40991-9PMID 41760832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease.

  2025cited by this paper
• Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia

  2025cited by this paper
• Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023

  2024cited by this paper
• Development and Validation of a Nomogram for Renal Survival Prediction in Patients with Autosomal Dominant Polycystic Kidney Disease

  2023cited by this paper
• Visceral fat and attribute-based medicine in chronic kidney disease

  2023cited by this paper
• Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study

  2022cited by this paper
• Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

  2022cited by this paper
• A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020

  2021cited by this paper
• Germline Mutations for Kidney Volume in ADPKD

  2021cited by this paper
• Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease

  2021cited by this paper
• Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD.

  2020cited by this paper
• Sex Differences in Time-Series Changes in Pseudo-R2 Values Regarding Hyperuricemia in Relation to the Kidney Prognosis

  2020cited by this paper
• Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease

  2020cited by this paper
• Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)

  2020cited by this paper
• Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study

  2020cited by this paper
• High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study

  2020cited by this paper
• Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study

  2020cited by this paper
• Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations

  2020cited by this paper
• Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis

  2019cited by this paper
• Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: A prospective cohort study

  2019cited by this paper
• A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression

  2019cited by this paper
• Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R2 Values in Relation to Renal Outcomes

  2019cited by this paper
• Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease

  2019cited by this paper
• HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease.

  2018cited by this paper
• HIF-1α drives cyst growth in advanced stages of autosomal dominant polycystic kidney disease.

  2018cited by this paper
• Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018

  2018cited by this paper
• Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease

  2017cited by this paper
• 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

  2017cited by this paper
• Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.

  2016cited by this paper
• Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

  2015cited by this paper
• A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• Prevalence of Anemia in Chronic Kidney Disease in the United States

  2014cited by this paper
• Preface: evidence-based clinical practice guidelines for CKD—an abridged English version

  2014cited by this paper
• The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences.

  2014cited by this paper
• Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.

  2013cited by this paper
• The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease

  2013cited by this paper
• Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies

  2013cited by this paper
• Renal disease progression in autosomal dominant polycystic kidney disease

  2012cited by this paper
• Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s).

  2012cited by this paper
• 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

  2010cited by this paper
• The role of the renin-angiotensin system in the regulation of erythropoiesis.

  2010cited by this paper
• Haemoglobin and erythropoietin levels in polycystic kidney disease.

  2007cited by this paper
• Relaxing the rule of ten events per variable in logistic and Cox regression.

  2007cited by this paper
• Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients.

  1985cited by this paper

• No citing papers are available for this paper.